Purchases and Sales Made in Q1 2023 in Prometheus Biosciences, Inc. (RXDX)
This table provides information about the institutional ownership of Prometheus Biosciences, Inc. (RXDX) during Q1 2023. The information is specifically focused on institutions that hold shares of Prometheus Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 10, 2023
Q1 2023
|
Decheng Capital Management Iii (Cayman), LLC
|
SELL
|
- |
-100K- 40.0% |
$10.3M - $12.6M
|
150K
$0
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-105K- 7.76% |
$10.8M - $13.2M
|
1.24M
$0
|
|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-108K- 66.23% |
$11.2M - $13.6M
|
55K
$0
|
|
|
May 15, 2023
Q1 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-163K- 56.42% |
$16.9M - $20.6M
|
126K
$0
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-164K- 44.5% |
$17M - $20.7M
|
205K
$0
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-164K- 44.5% |
$17M - $20.7M
|
205K
$0
|
|
|
May 12, 2023
Q1 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-188K- 40.71% |
$19.5M - $23.7M
|
274K
$0
|
|
|
May 15, 2023
Q1 2023
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-363K- 35.13% |
$37.5M - $45.8M
|
670K
$0
|
|
|
May 15, 2023
Q1 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-435K- 20.81% |
$45M - $54.9M
|
1.66M
$0
|
|
|
May 15, 2023
Q1 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-681K- 61.82% |
$70.5M - $86M
|
421K
$0
|